Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

InvestorPlace.com Editor’s Best (and Worst) Calls of 2011

Take a look back at InvestorPlace.com editor Jeff Reeve's 2011 stock pick gems like AmBev -- and duds like BofA.

3 Top Takeover Candidates for 2012

With acquirers hungry and loaded with cash, it could be a busy year for M&A. And these three companies could lead the list of likely buyout candidates.

AOL Investors Ask: How Much Longer?

After two years, CEO Tim Armstrong's turnaround is still not done. And now a big shareholder is getting antsy.

Netflix’s Reed Hastings Still Doesn’t Get It

Cutting his stock option award in half -- which still leaves it at $1.5 million -- is scant help for burned investors.

Gold, Silver Prices Mixed On Hopeful Economic Data

Stronger economic numbers lift silver while holding gold close to the flat line.

Intel Chipped By Shrinking Demand

Thai flooding this summer certainly made a dent in Intel's business this year, but there have been several indications that PC sales were slowing before that.

Yahoo’s Parts Are Worth More Than Its Sum

As the company mulls the sale of its Asian assets, its core operations are likely undervalued.

Precious Metals, Miners Lower as Jobless Claims Hit 44-Month Low

Gold and silver were off just less than 1% in Thursday morning trading, and mining shares were broadly lower as well.

Toyota in the Comeback Driver’s Seat for 2012

Toyota is projected to drop from No. 1 to No. 3 in global sales this year, but ambitious plans could propel TM back to the top spot.

The Case Against Arthur Sulzberger at The New York Times

His record as chairman since 1997 has been terrible for shareholders. NYT needs new blood as a leader , someone like Ford's Alan Mulally.

Walgreen Not Sweating Loss of Express Scripts Customers to CVS — Should It Be?

CVS says it could gobble up to 23M prescriptions that Walgreens has sold through Express Scripts if a deal isn't announced. So far, WAG is sticking to its guns.

Blame Bargains for Best Buy’s Demise

Best Buy's problem isn't unique among retailers -- businesses need sales to bring in price-conscious consumers, but their revenues are getting killed.

Oracle Decks Techs — Wednesday’s IP Market Recap

The software giant's first earnings miss in a decade didn't go over well.

Ariad Pharmaceuticals Still Might Have Upside

Ariad Pharmaceuticals is up 120% in the past 12 months, mostly fueled on optimism over its trial leukemia treatment. But some analysts think the ceiling is higher.

Gold, Silver Lower as Banks Flock to Borrow ECB Money

Eldorado Gold, Pan American Silver were among a few gainers going against the grain of downward-moving metal prices, miners Wednesday morning.

Oracle Sounds Another Warning Bell for Tech Sector

The stock took a big hit after missing earnings estimates, causing investors to grow more wary of the tech sector.

ConAgra Rolls as Market Rallies — Tuesday’s IP Market Recap

A pre-Christmas surge on Wall Street lifted many other stocks as well.

The Best and Worst Dow Stock of the Year

A fast-food giant is on top (up 29%), and a banking giant is on the bottom (down 61%). Get their names and see results for all 30 Dow stocks.

Where AT&T Stands After the T-Mobile Split

We can't say we didn't see it coming. Despite its desperate attempt to hitch up with T-Mobile, AT&T finally called the whole thing off. What happens next?